 |
|
|
|
|
|
 |
Biotechnology |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
Hip Health Plan of New York - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Group Health Cooperative - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Inova Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Intermountain Healthcare, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
LifePoint Hospitals, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Cml Healthcare Income Fund - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Clarian Health Partners, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Baylor Health Care System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Catholic Health Services of Long Island - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Catholic Healthcare Partners - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Christus Health - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Mayo Foundation for Medical Education and Research - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Jefferson Health System, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
MedCath Corporation - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Spectrum Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Sutter Health - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
XCounter Ab - Healthcare - Medical Equipment
SWOT Report
|
August 2008 |
£62 |
Xceed Biotechnology Limited - Healthcare - Medical Equipment
SWOT Report
|
August 2008 |
£62 |
Southern Cross Healthcare Group Plc - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Stille Ab - Healthcare - Medical Equipment
SWOT Report
|
August 2008 |
£62 |
Sisters of Mercy Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
NewYork- Presbyterian Hospital - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
New York City Health and Hospitals Corporation - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Providence Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Ramsay Health Care Limited - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£62 |
Scanlan International Inc. Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Spectrum Surgical Instruments Corporation Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Shofu Inc. Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Medikro Oy. Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Synergetics USA. Inc.Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Karl Storz Gmbh & Co. Kg Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Ontex International N.V. Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Schiller Ag Medical Equipment
Company Share Analysis
|
July 2008 |
£500 |
Biopharmaceuticals in South East Asia
|
July 2008 |
£795 |
Stem Cell Markets
|
July 2008 |
£1695 |
DNA Sequencing and PCR Markets
|
July 2008 |
£1695 |
Microscopy Markets
|
July 2008 |
£1695 |
Daiichi Sankyo:
Pipeline • Products • Performance • Potential
|
June 2008 |
£595 |
Daiichi Sankyo
Pipeline, Products, Performance, Potential
|
June 2008 |
£595 |
SNP Genotyping and Analysis Markets
|
June 2008 |
£2015 |
Booming Biotech Market in India
|
June 2008 |
£705 |
RNA Interference Markets
|
May 2008 |
£1010 |
Shionogi:
Pipeline • Products • Performance • Potential
|
April 2008 |
£595 |
Boehringer Ingelheim:
Pipeline • Products • Performance • Potential
|
April 2008 |
£595 |
Boehringer Ingelheim
Pipeline, Products, Performance, Potential
|
April 2008 |
£595 |
Shionogi
Pipeline, Products, Performance, Potential
|
April 2008 |
£595 |
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
|
April 2008 |
£1715 |
MarketWatch: Biotechnology
|
April 2008 |
£110 |
Biogenerics, The World Market
Biosimilars and Follow-On Biologics at a Crossroads
|
April 2008 |
£1765 |
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
A Study of Biotherapeutic Developers and Contract Manufacturing Organizations, 2007
|
April 2008 |
£805 |
Fastest Growing Biotechnology Companies, The
Growth Strategies, Comparative Analyses and Company Profiles
|
March 2008 |
£1995 |
Somaxon Pharmaceuticals Inc
Premium Company Profile
|
March 2008 |
£265 |
Threshold Pharmaceuticals Inc
Premium Company Profile
|
March 2008 |
£265 |
Proteomics
Technologies, Markets and Companies
|
March 2008 |
£1995 |
Indian Biotechnology Industry Report
|
March 2008 |
£600 |
Label Free Binding Analysis Trends 2008
|
March 2008 |
£1540 |
RNAi
Technologies, Markets and Companies
|
March 2008 |
£1645 |
Hanger Orthopedic Group, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Haemonetics Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Fresenius SE
Strategic Analysis Profile
|
February 2008 |
£400 |
F. Hoffmann-La Roche Ltd.
Strategic Analysis Profile
|
February 2008 |
£400 |
IDEXX Laboratories, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Gyrus Group PLC
Strategic Analysis Profile
|
February 2008 |
£400 |
KYOWA HAKKO KOGYO Co., Ltd.
Strategic Analysis Profile
|
February 2008 |
£400 |
Elekta AB
Strategic Analysis Profile
|
February 2008 |
£400 |
STERIS Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Luxottica Group S.p.A.
Strategic Analysis Profile
|
February 2008 |
£400 |
Philips Medical Systems
Strategic Analysis Profile
|
February 2008 |
£400 |
Orthofix International N.V.
Strategic Analysis Profile
|
February 2008 |
£400 |
Nobel Biocare Holding AG
Strategic Analysis Profile
|
February 2008 |
£400 |
Kinetic Concepts, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Invacare Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Accuray Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
Ansell Limited
Strategic Analysis Profile
|
February 2008 |
£400 |
Arrow International, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
B. Braun Melsungen AG
Strategic Analysis Profile
|
February 2008 |
£400 |
Alliance Imaging, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Air Liquide
Strategic Analysis Profile
|
February 2008 |
£400 |
ABIOMED, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Sectra AB
Strategic Analysis Profile
|
February 2008 |
£400 |
Bayer Healthcare
Strategic Analysis Profile
|
February 2008 |
£400 |
Biosite Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
DaVita Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Datascope Corp.
Strategic Analysis Profile
|
February 2008 |
£400 |
DJO Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
Coloplast AS
Strategic Analysis Profile
|
February 2008 |
£400 |
C. R. Bard, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Carl Zeiss Meditec AG
Strategic Analysis Profile
|
February 2008 |
£400 |
Edwards Lifesciences Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Straumann Holding AG
Strategic Analysis Profile
|
February 2008 |
£400 |
Thoratic Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Thermo Fisher Scientific Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
The Cooper Companies, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Wavelight AG check
Strategic Analysis Profile
|
February 2008 |
£400 |
Wright Medical Group, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Johnson & Johnson
Strategic Analysis Profile
|
February 2008 |
£400 |
bioMerieux S.A.
Strategic Analysis Profile
|
February 2008 |
£400 |
ZOLL Medical Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Terumo Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Teleflex Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
Sorin S.p.A.
Strategic Analysis Profile
|
February 2008 |
£400 |
SonoSite, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Smiths Medical
Strategic Analysis Profile
|
February 2008 |
£400 |
St. Jude Medical Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Siemens Medical Solutions
Strategic Analysis Profile
|
February 2008 |
£395 |
Synthes GmbH
Strategic Analysis Profile
|
February 2008 |
£400 |
Symmetry Medical Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Advances in Biopharmaceutical Technology in India
|
February 2008 |
£1995 |
DNA Sequencing
|
February 2008 |
£2235 |
Environmental Markets for Biotechnology
|
January 2008 |
£1205 |
China Molecular Diagnostics & Database Package
|
January 2008 |
£4000 |
High Throughput Screening
|
January 2008 |
£1525 |
Biomarkers
|
January 2008 |
£1645 |
Cell Based Label-Free Detection Trends 2007
|
January 2008 |
£1540 |
Launching Combination Products
Brand Extension and Franchise Development Strategies
|
January 2008 |
£1995 |
Stem Cell Research
|
January 2008 |
£2110 |
Innovations in Bioinformatics
Emerging Tools for Drug Discovery and Development
|
January 2008 |
£1995 |
Metabolomics
|
January 2008 |
£1370 |
Biological Implants
|
January 2008 |
£1885 |
Angiogenesis Modulators
|
January 2008 |
£1390 |
Indian Biopharmaceuticals
|
January 2008 |
£600 |
hERG Screening
|
January 2008 |
£1465 |
Antibiotics and Drug Resistance 2008
Drug Innovation and the Strategy to Combat - Antibiotic Resistance Mechanisms
|
January 2008 |
£1499 |
Apoptosis
|
January 2008 |
£1440 |
Indian Biotechnology
|
January 2008 |
£600 |
China Biotech 2008 & Database Package
|
January 2008 |
£500 |
China Pharmaceutical & Biotechnology Monthly
|
January 2008 |
£2000 |
ADME/TOX Technologies
|
January 2008 |
£1450 |
China Vaccine & Database Package
|
December 2007 |
£4000 |
TR-FRET Based Assay Trends 2008
|
December 2007 |
£1540 |
Immunogenicity to Biologics
Implications Of Reactions Against Biotech Drugs
|
November 2007 |
£1450 |
Premium Company Profile: Invitrogen Corporation
|
November 2007 |
£265 |
Premium Company Profile: BioMarin Pharmaceutical Inc.
|
November 2007 |
£265 |
RNAi Therapeutics 2008
|
November 2007 |
£2350 |
Biomarkers
The Expanding Global Market
|
November 2007 |
£2410 |
Biosimilars: a viable market?
|
October 2007 |
£995 |
Biotechnology
Global Industry Guide
|
October 2007 |
£475 |
Biosimilars Series
Strategic Issues - Potential Remains Uncertain
|
October 2007 |
£2000 |
Building Pharmaceutical-Biotechnology Partnerships and Alliances
Market Preparation & Strategic Support
|
October 2007 |
£3530 |
Pharmaceutical Biotechnology: Fundamentals and Applications
Third Edition
|
October 2007 |
£115 |
Monoclonal Antibodies Report Part II
Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff
|
September 2007 |
£3800 |
Global Biotechnology
IBISWorld Industry Report
|
September 2007 |
£370 |
Global Protein Therapeutics Market Analysis
|
September 2007 |
£895 |
U.S. Bioethanol & Cellulosic Ethanol Market & Future Direction
|
September 2007 |
£545 |
China Biotherapeutics Database 2006
|
September 2007 |
£1005 |
Biomanufacturing Strategies
Market Drivers, Build-Vs-Buy Decisions And Opportunities In Contract Relationship Management
|
September 2007 |
£1495 |
Microplate Mixing Trends 2007
|
September 2007 |
£1540 |
Stem Cells 2007-2008
|
September 2007 |
£2350 |
Biopharmaceutical Products in the US and European Markets
6th Edition
|
September 2007 |
£750 |
World Enzymes
Study # 2229
|
September 2007 |
£2680 |
Biomet Medical Device Company Intelligence Report
|
August 2007 |
£396 |
Biotechnology in Australia
IBISWorld Industry Report
|
August 2007 |
£340 |
Biotechnology in Europe
|
August 2007 |
£125 |
Biotechnology in France
|
August 2007 |
£125 |
Biotechnology in China
|
August 2007 |
£125 |
Biotechnology in Canada
|
August 2007 |
£125 |
Biotechnology in Asia-Pacific
|
August 2007 |
£125 |
Biotechnology in Belgium
|
August 2007 |
£125 |
Biotechnology in the United States
|
August 2007 |
£125 |
Biotechnology in Germany
|
August 2007 |
£125 |
Biotechnology in the Netherlands
|
August 2007 |
£125 |
Biotechnology in the United Kingdom
|
August 2007 |
£125 |
Biotechnology in Spain
|
August 2007 |
£125 |
Biotechnology in Japan
|
August 2007 |
£125 |
Global Biotechnology
|
August 2007 |
£125 |
Biotechnology in Italy
|
August 2007 |
£125 |
Pigments: Inorganic, Organic & Specialty
|
August 2007 |
£2235 |
Personalized Medicine
|
August 2007 |
£990 |
Global Biotechnology Industry 2006 - Power Point Presentation (Editable)
|
July 2007 |
£400 |
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts:
The Challenge Of Turning Technology Into Therapy
|
July 2007 |
£1999 |
Cell Therapeutics Inc - SWOT Analysis
|
July 2007 |
£63 |
Global Biotechnology -Yearly Update 2006
|
July 2007 |
£600 |
Company Study of Shanghai Kehua Bio-engineering Co.
Ltd., 2007
|
July 2007 |
£150 |
Nanotoxicology: Characterization, Dosing and Health Effects
|
July 2007 |
£432 |
Monoclonal Antibodies Report Part I
|
June 2007 |
£3800 |
Monoclonal Antibodies Report Market Model
|
June 2007 |
£3800 |
Biomarkers and Tests for Pharma/ Biotech R&D
Companies, Products and Worldwide Market, 2006-2011
|
June 2007 |
£1290 |
China Pharmaceutical Profiles
|
June 2007 |
£2000 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
Ion Channel Trends 2007
|
June 2007 |
£1540 |
DNA Sequencing Equipment and Services Markets
|
June 2007 |
£1765 |
BIOTECH 2007 Life Sciences
A Global Transformation
|
May 2007 |
£220 |
Minimally Invasive Spine Surgery
|
May 2007 |
£145 |
Multi-Mode Microplate Reader Trends 2007
|
May 2007 |
£1540 |
Cardiovascular Multidetector CT Angiography
|
May 2007 |
£99 |
Canadian Biotech News Industry Report
|
April 2007 |
£695 |
High-Content Analysis 2007
|
April 2007 |
£1540 |
China Antibodies & Database Package
|
April 2007 |
£2000 |
Biogenerics & Therapeutic Proteins
A Competitor Analysis
|
April 2007 |
£915 |
Becton-Dickinson Medical Device Company Intelligence Report
|
March 2007 |
£395 |
US Biotech Market Analysis
|
March 2007 |
£495 |
The Dynamic Media, Sera and Reagent Market in Biotechnology
|
March 2007 |
£2410 |
Fluorescence Lifetime Trends 2007
|
March 2007 |
£1540 |
China Biopharmaceutical Industry Report, 2006-2007
|
March 2007 |
£150 |
Biocompatible Materials for the Human Body
|
March 2007 |
£2410 |
Analogic Medical Device Company Intelligence Report
|
February 2007 |
£395 |
Siemens Medical Solutions Medical Device Company Intelligence Report
|
February 2007 |
£395 |
Biotech Drug Delivery Systems
Key Company Intelligence & Market Outlook to 2012
|
February 2007 |
£1299 |
Indian Biotechnology Market Outlook (2006)
|
February 2007 |
£695 |
RNAi/MicroRNA 2007
|
February 2007 |
£2350 |
Separation Systems for Commercial Biotechnology
|
February 2007 |
£2410 |
Bio/Chemical Sensors
The Bourne Report
|
February 2007 |
£695 |
Biomarkers: A Market Briefing
A Market Briefing
|
January 2007 |
£1005 |
Stem Cells - The hype and the hope
Business opportunities and forecasts
|
January 2007 |
£4999 |
Analysis Report on Major Enterprises in the Chinese Bearing Industry
|
January 2007 |
£150 |
Genetically Modified Crops
Industry Report
|
January 2007 |
£400 |
Indian Biopharmaceuticals Industry Report
|
January 2007 |
£400 |
Biotechnology in the US
IBISWorld Industry Report
|
January 2007 |
£325 |
A Guide to Biosimilars, Biogenerics and Follow-on Biologics
|
January 2007 |
£1095 |
Scrip's Pharmaceutical Company League Tables 2007
|
January 2007 |
£1870 |
Clinica's Guide to Early-stage Medtech Companies
|
January 2007 |
£500 |
Microplate Instrument Trends 2007
|
January 2007 |
£1540 |
Monoclonal Antibody Therapy
Sector Snapshot
|
January 2007 |
£250 |
Cell Culture
The World Market for Media, Sera, and Reagents
|
January 2007 |
£1970 |
The China Pharmaceutical Market: A Strategic Opportunity Analysis
|
January 2007 |
£600 |
Market for Bioengineered Protein Drugs; The
|
January 2007 |
£2410 |
Applied Biosystems Group
|
December 2006 |
£150 |
Biosimilars: Benchmarking the key players
With increasing regulatory clarity and high revenue potential, interest in biosimilars increases
|
December 2006 |
£4000 |
Biosimilars: Regulatory Issues
Europe continues to make strides while the US lags behind
|
December 2006 |
£2000 |
Biotechnology: Global Industry Guide
|
December 2006 |
£530 |
Biopartnering Strategies
Maximizing returns from biotechnology deal-making
|
December 2006 |
£1495 |
Global Market for Antimicrobials and Antifungals; The
Challenging Resistance to 2016
|
December 2006 |
£1600 |
Next Generation Battery
U.S. Biofuel Cells R&D and Future Directions
|
October 2006 |
£655 |
New Opportunities in US Biofuel Market (2006)
|
September 2006 |
£595 |
Global Biotech Report 2006, The
The rise of the Biotech blockbusters
|
September 2006 |
£4999 |
Competitor Analysis: Wet Age-Related Macular Degeneration (AMD)
|
September 2006 |
£132 |
Biocompatible Materials
US industry forecasts to 2010 & 2015
|
September 2006 |
£2185 |
Wet Age-Related Macular Degeneration (AMD)
Competitor Analysis
|
September 2006 |
£132 |
Advances in Biopharmaceutical Technology in China
|
September 2006 |
£3410 |
Chinese Markets for Biotechnology
|
August 2006 |
£1985 |
China Industrial Biotechnology
|
August 2006 |
£4000 |
Commercial Insight: Antidyslipidemics
Branded statins beware, generics are amongst you
|
July 2006 |
£8440 |
Protein and Antibody Microarrays Markets
Sector Snapshot
|
July 2006 |
£250 |
Bioinformatics Market Update (2006)
|
July 2006 |
£395 |
Biofuel Market Worldwide (2006)
|
July 2006 |
£695 |
Bioinformatics Markets
Strategies, Business Models and Trends for the Future
|
June 2006 |
£1690 |
Global Biotechnology Industry 2006
|
June 2006 |
£550 |
Biogenerics
Competitor Analysis
|
June 2006 |
£526 |
In Silico ADME/Tox Products Market 2006
|
June 2006 |
£1540 |
Future of BioSciences; The
Four Scenarios for 2020 and Their Implications for Human Healthcare
|
June 2006 |
£1500 |
Biotech 2010
|
June 2006 |
£2410 |
Automated Low Volume Dispensing Trends 2006
|
June 2006 |
£1540 |
Biotech in Autoimmune and Inflammatory Disease 2006
2nd Edition
|
May 2006 |
£1490 |
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets
2006-2011 Analysis & Forecasts
|
May 2006 |
£545 |
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities
2006-2011 Analysis & Forecasts
|
May 2006 |
£890 |
China Bio-services & Database Package
|
May 2006 |
£2000 |
Medical and Biological Sensors and Sensor Systems
Markets, Applications, and Competitors Worldwide, 2nd Edition
|
May 2006 |
£1765 |
China Custom Chemical Synthesis & Database Package
|
April 2006 |
£500 |
Label Free Detection Trends 2006
|
April 2006 |
£1540 |
Labeling and Linkage Agents for Immunoassays and Gene Probes
|
April 2006 |
£2410 |
India: Pharmaceutical and biotechnology opportunities
|
April 2006 |
£600 |
Microarray Markets
|
March 2006 |
£990 |
|
|
